AzTrials
AzTrials

Carpal Tunnel SyndromePhase 4NCT03196817

Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration

A Phase 4 study testing betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2% and Wrist splinting in people with Carpal Tunnel Syndrome, run by Hospital Alvorada at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Carpal tunnel syndrome (CTS) is the most common neuropathic compression syndrome of the upper limbs, caused by compression of the median nerve in the wrist. There is no gold standard for establishing the diagnosis of STC. The diagnosis can be based on clinical findings and electrodiagnostic tests. Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Carpal Tunnel Syndrome
What is being tested?
betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2% and Wrist splinting
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteBrazil
Study dates
1 Aug 2016to Dec 2017
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients aged 40 years or more,
  • Have the diagnosis confirmed with electromyography (EMG),
  • Four or more than six of the following clinical signs and symptoms suggested by Graham et al (CTS-6):
  • Paraesthesia in the territory of the median nerve.
  • Night hand paresthesia
  • Atrophy of thenar muscles
Show all 18Show fewer
  • Positive Tinel Sign
  • Phalen Test Positive
  • Loss of two point discrimination
  • Sign a Research Ethics Committe, after reading and explanation of the proposed study.
  • Non-inclusion criteria:
  • Pretreatment with corticosteroids and splint
  • Prior surgical treatment
  • Traumatic or nontraumatic pathologies associated
  • Hypersensitivity to corticosteroids
  • CTS secondary to other pathology
  • Refusal to sign a Research Ethics Committe.
  • Fixed Paresthesia

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Jesus Queiroz junior

    São Paulo, 03325000

Other trials in Brazil

About this study

Official title: Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration: Clinical Randomized Trial

Carpal tunnel syndrome (CTS) is the most common neuropathic compression syndrome of the upper limbs, caused by compression of the median nerve in the wrist. There is no gold standard for establishing the diagnosis of STC. The diagnosis can be based on clinical findings and electrodiagnostic tests. Treatment options can be divided into surgical and non-surgical procedures. Surgical interventions include open carpal tunnel release, mini incision or release of the endoscopic carpal tunnel. Nonsurgical include daily activities modification, oral anti-inflammatory drugs (NSAIDs), oral corticosteroids, splints, corticosteroid injections or other options (laser therapy, ultrasound or acupuncture)

The aim of this study is to compare randomly, conservative treatment for CTS with night splint of the wrist versus local infiltration of corticosteroids after a min-imum period of six months follow-up.

Patients will be divided into two groups: night orthesis group that will receive the prescription to purchase the orthesis and guide the use of it; and infiltration group of patients will be referred to the Moema Alvorada Hospital to carry out infiltration. These patients will be evaluated before application, one week, one month, three months and six months after intervention.

Read the detailed description

This study will be developed in the service of medical residency of surgery and microsurgery of the hand of Alvorada hospital (São Paulo - SP).

The Study Design is Randomized clinical trial according to the CONSORT STATEMENT (http://www.consort-statement.org) standards.

The number of participants will initially be 84 patients.

Inclusion criteria:

Adult patients 40 years of age or older with four or more of the following clinical signs and symptoms suggested by Graham et al. (CTS-6):

  1. Paresthesia in the territory of the median nerve.
  2. Nocturnal paresthesia of the hand
  3. Atrophy of the tenar musculature
  4. Positive Tinel Signal
  5. Positive Phalen Test
  6. Loss of discrimination of 2 points

All patients will be diagnosed with electromyography (EMG). All participants will sign an Research Ethics Committee of this institution, after reading and explaining the study proposal.

Criteria for non-inclusion:

Previous treatment with corticosteroids and felling in the last 6 months Previous surgical treatment Associated traumatic or non-traumatic pathologies Hypersensitivity to corticosteroids. CTS secondary to another pathology. Refusal to Research Ethics Committe. Fixed paresthesia

Randomization and Allocation:

The allocation of patients to the infiltration or nocturnal orthosis groups will be performed using opaque and numbered envelopes on their outer face with consecutive numbers. The draw of the method, for each envelope, will be done randomly and sequentially, using randomization software (available at: http://www.random.org), after the randomization, the envelopes will be sealed. The sealed envelope, containing the patient's allocation group, will be opened only at the doctor's office after verification of the criteria for inclusion and signing of the Research Ethics Committee signature. The randomization procedure was performed by a person not directly involved in the study.

Sampe Size:

Considering the difference of 30% in the improvement of nocturnal paresthesia, 95% confidence interval and statistical power of 80%, we calculated a sample of 84 patients. At 6 months

Interventions

The patients included in this study will be attended at the Santa Cruz IV Ambulatory of hand surgery outpatient clinic. Patients with a diagnosis of CTS will be referred for evaluation in this outpatient clinic.

After confirmation of the diagnosis of CTS with the presence of four or more of the six criteria proposed by Graham and confirmation by the EMG and application of the inclusion and non inclusion criteria in the study, eligible patients will be informed about the nature and purpose of the study, by reading the Research Ethics Committee of this institution; after signing will be registered. Only after signing the Research Ethics Committee and the patient's registration will the opaque and sealed envelope containing the patient's allocation be opened. Patients in the nocturnal orthoses group will receive prescriptions for the purchase of the orthosis and guidance on use at the same moment of randomization. Patients in the infiltration group will be referred to the Hospital Alvorada de Moema to perform the infiltration at the same moment of randomization.

Infiltration technique:

Patient seated, with elbow resting on the table, supine wrist, relaxed in dorsiflexion, after asepsis and antisepsis care a needle will be inserted located on the ulnar border of the radial flexor tendon of the carpus, with an angle of 30º directed to the carpal tunnel , with an association of betamethasone dipropionate, betamethasone disodium phosphate {diprospan®}, plus lidocaine (xylocaina®).

Night immobilization:

During the night time, the patient will wear a forearm-palmar splint, where the wrist will remain in the 15th degree of extension, until its removal in the morning. The nocturnal orthosis should be used by study period .

Outcomes

Primary Outcomes:

  1. Remission of nocturnal paresthesia after intervention - Evaluation to verify remission of nocturnal paresthesia, referred by the patient at the time of initial care.
  2. Boston Questionnaire (Levine):

A questionnaire developed for the purpose of evaluating the severity of symptoms and the degree of manual ability of patients with CTS. This is a self-reported questionnaire that assesses the severity of symptoms and the functional status of patients.

Secondary Outcome Measures:

  1. Visual Analogue Scale - EVA Pain Evaluation - The analogical visual scale of pain is formed by two bars, joined by a line with ten centimeters, that mark the beginning and the end. The start bar is "0" and indicates no pain. The end bar is the "10" and indicates the maximum pain. The patient was asked to register his pain with a stroke on that line joining the two bars. The gauging of the pain was performed by measuring the distance between the initial bar and the trait performed by the patient.
  2. Graham Criteria - CTS-6 Assessment of improvement of graham's cervix, which are signs and symptoms used for the diagnosis of CTS
Being tested
betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%, Wrist splinting
Keywords
Random Allocation, Injections, Orthotic Devices
Medical subject headings
Carpal Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%Drug

    Also called Steroid injection

    6.43 mg of betamethasone dipropionate, 2.63 mg of betamethasone disodium phosphate and 0.5 ml plus lidocaine 2%

  • Wrist splintingDevice

    Also called wrist splints

    Splinting only at night to maintain the wrist positioned in 15 degrees of extensionin.

Study groups in NCT03196817
Study groupRoleWhat they receive
Carpal tunnel injectionActive comparatorCarpal tunnel injection (infiltration) group of patients will be referred to the Hospital Alvorada to carry out steroid injection. The injection in carpal tunnel will be an association of 6.43 mg of betamethasone dipropionate, 2.63 mg of betamethasone disodium phosphate and 0.5 ml plus lidocaine 2%, totaling 1.5 ml.
Receives: Drug: betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%
Wrist splintingActive comparatorWrist splinting will be use in the nigth time, remain the wrist in the 15th degree in extension, until its removal in the morning.
Receives: Device: Wrist splinting

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Remission of symptoms

    Remission of nocturnal paresthesia referred by the patient at six months the follow up.

    Measured: 6 months

  2. Boston Questionnaire (Levine)

    A questionnaire developed for the purpose of evaluating the severity of symptoms and the degree of manual ability of patients with CTS.

    Measured: 6 months

Secondary outcomes (2)
  1. Visual Analogue Scale - EVA Pain Evaluation

    The analogical visual scale of pain is formed by two bars, joined by a line with ten centimeters, that mark the beginning and the end. The start bar is "0" and indicates no pain. The end bar is the "10" and indicates the maximum pain.

    Measured: 6 months

  2. Graham Criteria - CTS-6

    Assessment of improvement of graham's cervix, which are signs and symptoms used for the diagnosis of CTS

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2017
  2. Study start1 Aug 2016
  3. Primary completion1 May 2017
  4. Study completionDec 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Investigator
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03196817
Sponsor's protocol ID
HAMJQ01
Status last verified
Jun 2017
First submitted
21 Oct 2016
Last updated
14 Aug 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes

Publications

  • Chen PC, Chuang CH, Tu YK, Bai CH, Chen CF, Liaw M. A Bayesian network meta-analysis: Comparing the clinical effectiveness of local corticosteroid injections using different treatment strategies for carpal tunnel syndrome. BMC Musculoskelet Disord. 2015 Nov 19;16:363. doi: 10.1186/s12891-015-0815-8.

    PubMed 26585378
  • Ly-Pen D, Andreu JL, Millan I, de Blas G, Sanchez-Olaso A. Comparison of surgical decompression and local steroid injection in the treatment of carpal tunnel syndrome: 2-year clinical results from a randomized trial. Rheumatology (Oxford). 2012 Aug;51(8):1447-54. doi: 10.1093/rheumatology/kes053. Epub 2012 Mar 30.

    PubMed 22467087
  • Meems M, Den Oudsten B, Meems BJ, Pop V. Effectiveness of mechanical traction as a non-surgical treatment for carpal tunnel syndrome compared to care as usual: study protocol for a randomized controlled trial. Trials. 2014 May 22;15:180. doi: 10.1186/1745-6215-15-180.

    PubMed 24886455
  • Graham B, Regehr G, Naglie G, Wright JG. Development and validation of diagnostic criteria for carpal tunnel syndrome. J Hand Surg Am. 2006 Jul-Aug;31(6):919-24.

    PubMed 16886290
  • Peters-Veluthamaningal C, Winters JC, Groenier KH, Meyboom-de Jong B. Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice. BMC Fam Pract. 2010 Jul 29;11:54. doi: 10.1186/1471-2296-11-54.

    PubMed 20670438
  • Ucan H, Yagci I, Yilmaz L, Yagmurlu F, Keskin D, Bodur H. Comparison of splinting, splinting plus local steroid injection and open carpal tunnel release outcomes in idiopathic carpal tunnel syndrome. Rheumatol Int. 2006 Nov;27(1):45-51. doi: 10.1007/s00296-006-0163-y. Epub 2006 Jul 27.

    PubMed 16871409
  • Carlson H, Colbert A, Frydl J, Arnall E, Elliot M, Carlson N. Current options for nonsurgical management of carpal tunnel syndrome. Int J Clin Rheumtol. 2010 Feb;5(1):129-142. doi: 10.2217/IJR.09.63.

    PubMed 20490348

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2% and Wrist splinting in people with Carpal Tunnel Syndrome, run by Hospital Alvorada at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 18 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Remission of symptoms (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03196817, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in